SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF (VTI) remains a central focus as investors grapple with the broader market's heavy reliance on a handful of large-cap tech stocks and ongoing economic uncertainty. The community is actively debating the sustainability of current AI-driven valuations and broader infrastructure bottlenecks, with many viewing VTI as a critical defensive anchor amidst ongoing volatility.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following segments: Walmart U.S., Walmart International, and Sam's Club U.S. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club U.S. segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is facing significant selling pressure after reporting its slowest U.S. comparable sales growth in six years, sparking broader concerns among investors about the resilience of the everyday consumer. While the community is debating whether this pullback represents an attractive long-term entry point or a sign of deeper economic weakness, many are closely watching the company’s strategic pivot toward high-margin advertising and digital services.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is seeing significant bullish momentum as the community monitors its recovery from recent security concerns and technical breakouts, with many traders drawing parallels to Bitcoin's early growth. Investors are closely tracking key resistance levels, fueled by speculation surrounding a potential ETF catalyst and the active accumulation strategies of major stakeholders.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to Ether. It operates through the following segments: ETH Treasury Management and Affiliate Marketing. The ETH Treasury Management segment focuses on the accumulation and active management of ETH as a long-term treasury asset. The Affiliate Marketing segment focuses on performance-based customer acquisition services for sportsbooks and online casino gaming operators worldwide. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is trending as community discussions focus on its massive Ethereum treasury and the potential for a significant price recovery if regulatory clarity passes and ETH continues its rally. Investors are actively debating the stock's deep discount to net asset value, with many monitoring institutional buying patterns and long-dated call options as indicators of a possible turnaround.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as investors show renewed optimism, fueled by broader crypto market momentum and persistent speculation surrounding potential future ties to Elon Musk's companies. The community remains deeply divided, with many long-term holders actively calling for a push toward the one-dollar milestone while others trade based on technical indicators and short-term volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Investors are closely watching for potential Phase 3 clinical trial results for MoonLake's psoriatic arthritis treatment as the company faces a critical reporting deadline and speculation regarding its strategic path forward. Sentiment remains split between long-term optimism over the pipeline's potential and frustration with management's communication style and recent dilution activities.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF is seeing increased attention as investors closely track institutional accumulation and key clinical trial catalysts within the sector, with community discourse centered on potential partnership and buyout activity for specific biotech holdings. Market participants are navigating sector-wide volatility by evaluating the relative strength of individual companies against broader index movements and upcoming FDA decision dates.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Investors are closely monitoring geopolitical tensions in the Middle East and their potential impact on oil prices and inflation, while simultaneously digesting mixed retail earnings and upcoming macroeconomic data to gauge the Federal Reserve's policy trajectory. The market remains focused on balancing bullish sentiment from AI infrastructure investments against concerns over elevated valuations and the impact of sustained high interest rates.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending following the launch of its v5.0.0 mainnet upgrade, which introduces features like post-quantum account support, while community members actively debate its long-term potential versus concerns about historical price performance and supply dilution.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is generating significant community conversation following its recent financial reports, with investors closely watching the company's operational ramp-up and efforts to secure a TAC agreement. While some express frustration over volatility and trust, many bulls highlight the stock's low-cost production profile and potential for a re-rating as supply-demand dynamics shift.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's How Much You Would Have Made Owning Incyte Stock In The Last 20 Years

Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.29% on an annualized basis producing an average annual return of 17.52%. Currently, Incyte has a market capitalization of $25.75 billion.read more...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Incyte Corporation (Nasdaq: INCY) announced today that it granted restricted stock unit awards (RSUs) representing an aggregate of 21,556 shares of the Companys common stock and stock option awards to purchase an aggregate of 18,172 shares of the Companys common stock to 24 new employees. The...

Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised

MIRM Q2 earnings miss estimates while revenues beat the same, as Livmarli and bile acid drugs fuel growth, prompting a higher 2026 sales outlook.

REGN or INCY: Which Is the Better Value Stock Right Now?

REGN vs. INCY: Which Stock Is the Better Value Option?

New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS

New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS PR Newswire SINGAPORE, Aug. 2, 2026 Minjuvi (tafasitamab), in combination with rituximab and lenalidomide, is the first...

Here's Why Incyte (INCY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Incyte Shares Retreat After Best Day In A Year Despite Opzelura EU Nod

Equity

The European Commission on Wednesday approved Incyte’s Opzelura cream as the first steroid-free topical treatment of its kind for adults with moderate eczema who do not get enough relief from standard creams.


Here's Why Incyte (INCY) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Opzelura (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Opzelura (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate...

Incyte Says It's No Longer A One-Drug Story

Incyte (INCY) Q2 earnings beat estimates with $1.67B revenue, $3.09 EPS. Full-year sales guidance raised. Shares rally to new 52-week high.read more...

$INCY Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.92 up 39.71% YoY
• Reported revenue of $1.67B up 37.72% YoY
• Incyte is raising its fiscal year 2026 total net sales guidance to $5,130 - $5,260 million, while total GAAP R&D and SG&A operating expense guidance is $4,915 - $4,995 million.

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Incyte Corp.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$127.81
Prev Close	$127.22
Open	$126.45
Dividend Yield	0.00%
50-Day Moving Average	$116.20
Beta	0.53
Avg. Volume	1.93M
PE Ratio	16.29

52-Week High	$132.60
52-Week Low	$81.09
Market Capitalization	$25.91B
EPS (Annual)	$6.41
Price to Book	4.05
Revenue Per Employee	$1.81M

Feed

News

Sentiment

Earnings

Fundamentals

Info